COMPANY OVERVIEW
"Our Mission is to Bring Evidence-Based Botanicals Into Oncology Standard of Care"
About LifeBiotic
LifeBiotic is a clinical-stage botanical biopharma company developing proprietary, pharma-grade botanical formulations for oncology.
Our work focuses on two major areas of unmet need: evidence-based supportive care during cancer treatment, and investigational botanical drug development
for recurrence-risk reduction.
Our lead drug candidate is currently being evaluated in an active Phase 2 clinical trial for bladder cancer at Rambam Health Care Campus.
Science Is Our Foundation
Science is not a marketing point at LifeBiotic. It is the foundation of our work.
We work in collaboration with renowned oncologists and scientists from leading Hospitals and Cancer Centers, including Harvard University, MD Anderson, Sheba Hospital, Ichilov Medical Center, Rmbam Health Campous and more.
Every formulation is developed through evidence-based methodology, designed for reproducibility, and evaluated with the rigor expected of a pharmaceutical program. We do not ask whether botanical medicine can meet clinical standards. We develop it to meet them.
Multi-Pathway, Multi-Targeted Platform
Human biology is complex. Oncology care is complex. Our platform is designed for that reality.
LifeBiotic’s patented formulations are built around multi-compound, multi-targeted botanical combinations, designed to engage multiple biological pathways at once.
This platform approach is the scientific foundation of our pipeline and the intellectual property that protects it.
From Plant to Clinical Protocol
We control the full development chain: sourcing, extraction, standardization, batch-to-batch verification, and clinical testing.
That means the formulation evaluated in research is produced with the same commitment to consistency, quality, and reproducibility expected in clinical development.
The Next Generation of Botanical Medicine
Our trials are conducted in hospital settings. Our data has been published in peer-reviewed journals. Our development process is built around scientific accountability.
LifeBiotic’s supportive care formulations have been evaluated in published randomized clinical trials. Our lead investigational drug candidate prevention of bladder cancer recurrence is currently being studied in a Phase 2 clinical trial at Rambam Health Care Campus.
With 15 years of research, 10 peer-reviewed publications, and multiple international patents, LifeBiotic is helping define a new category of botanical medicine — one grounded in clinical evidence, pharmaceutical standards, and a clear commitment to patients.